These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

989 related items for PubMed ID: 17190843

  • 1. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
    Campbell RK.
    Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
    [Abstract] [Full Text] [Related]

  • 2. Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus.
    Langley AK, Suffoletta TJ, Jennings HR.
    Pharmacotherapy; 2007 Aug; 27(8):1163-80. PubMed ID: 17655515
    [Abstract] [Full Text] [Related]

  • 3. DPP-4 inhibitors and their potential role in the management of type 2 diabetes.
    Barnett A.
    Int J Clin Pract; 2006 Nov; 60(11):1454-70. PubMed ID: 17073841
    [Abstract] [Full Text] [Related]

  • 4. The role of vildagliptin in the management of type 2 diabetes mellitus.
    Kleppinger EL, Helms K.
    Ann Pharmacother; 2007 May; 41(5):824-32. PubMed ID: 17456545
    [Abstract] [Full Text] [Related]

  • 5. Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes.
    Havale SH, Pal M.
    Bioorg Med Chem; 2009 Mar 01; 17(5):1783-802. PubMed ID: 19217790
    [Abstract] [Full Text] [Related]

  • 6. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    Neumiller JJ, Wood L, Campbell RK.
    Pharmacotherapy; 2010 May 01; 30(5):463-84. PubMed ID: 20411998
    [Abstract] [Full Text] [Related]

  • 7. Incretin mimetics and dipeptidyl peptidase-IV inhibitors: potential new therapies for type 2 diabetes mellitus.
    Triplitt C, Wright A, Chiquette E.
    Pharmacotherapy; 2006 Mar 01; 26(3):360-74. PubMed ID: 16503716
    [Abstract] [Full Text] [Related]

  • 8. Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug.
    Idris I, Donnelly R.
    Diabetes Obes Metab; 2007 Mar 01; 9(2):153-65. PubMed ID: 17300591
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
    Pratley RE, Salsali A.
    Curr Med Res Opin; 2007 Apr 01; 23(4):919-31. PubMed ID: 17407649
    [Abstract] [Full Text] [Related]

  • 10. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition.
    Kirby M, Yu DM, O'Connor S, Gorrell MD.
    Clin Sci (Lond); 2009 Sep 28; 118(1):31-41. PubMed ID: 19780719
    [Abstract] [Full Text] [Related]

  • 11. Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes.
    Nielsen LL.
    Drug Discov Today; 2005 May 15; 10(10):703-10. PubMed ID: 15896683
    [Abstract] [Full Text] [Related]

  • 12. Gliptins: a new class of oral hypoglycaemic agent.
    Chahal H, Chowdhury TA.
    QJM; 2007 Nov 15; 100(11):671-7. PubMed ID: 17881415
    [Abstract] [Full Text] [Related]

  • 13. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ.
    J Am Pharm Assoc (2003); 2009 Nov 15; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [Abstract] [Full Text] [Related]

  • 14. From the bench to the bedside: dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents.
    Pei Z.
    Curr Opin Drug Discov Devel; 2008 Jul 15; 11(4):512-32. PubMed ID: 18600568
    [Abstract] [Full Text] [Related]

  • 15. Incretins and other peptides in the treatment of diabetes.
    Todd JF, Bloom SR.
    Diabet Med; 2007 Mar 15; 24(3):223-32. PubMed ID: 17263764
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J.
    Consult Pharm; 2009 Jun 15; 24 Suppl B():11-7. PubMed ID: 19555131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.